Human immunodeficiency virus infection and hepatitis C pathology

Area of Science:

• Hepatology
• Immunology
• Virology

Background:

• Chronic hepatitis C virus (HCV) infection is a major cause of liver disease.
• Hepatitis C virus-related liver disease progression can be influenced by co-infections.
• Human immunodeficiency virus (HIV) co-infection is common in patients with chronic hepatitis C.

Purpose of the Study:

• To investigate the influence of HIV infection on liver disease severity in patients with chronic hepatitis C.
• To evaluate liver morphology and necro-inflammatory changes in HIV-positive versus HIV-negative patients with chronic hepatitis C.
• To determine the role of CD4+ lymphocyte counts in modulating liver disease in HCV/HIV co-infection.

Main Methods:

• Liver morphology was assessed in 160 HBsAg-negative patients with chronic hepatitis C.
• The study included 68 HIV-positive and 92 HIV-negative participants.
• Necro-inflammatory lesion severity was compared between groups based on CD4+ lymphocyte counts.

Main Results:

• No significant differences in liver lesion severity were observed between HIV-negative and HIV-positive patients when CD4+ counts exceeded 400 cells/mm3.
• HIV-positive patients with CD4+ counts below 400 cells/mm3 exhibited significantly lower grades of portal inflammation and piecemeal necrosis.
• These findings indicate a CD4+ count-dependent effect of HIV on liver pathology in chronic hepatitis C.

Conclusions:

• Liver lesions in hepatitis C appear to be significantly influenced by immunomediated mechanisms.
• HIV co-infection, particularly with lower CD4+ counts, may attenuate the inflammatory response in hepatitis C-related liver disease.
• Understanding these immune interactions is crucial for managing HCV/HIV co-infected patients.